Isolation of cancer stem cells by selection for miR-302 expressing cells

Background Cancer stem cells are believed to be a major reason for long-term therapy failure because they are multi-drug resistant and able to rest mitotically inactive in the hypoxic center of tumors. Due to their variable number and their often low proliferation rate, cancer stem cells are difficu...

Full description

Bibliographic Details
Main Authors: Karim Rahimi, Annette C. Füchtbauer, Fardin Fathi, Seyed J. Mowla, Ernst-Martin Füchtbauer
Format: Article
Language:English
Published: PeerJ Inc. 2019-03-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/6635.pdf
_version_ 1797418444117770240
author Karim Rahimi
Annette C. Füchtbauer
Fardin Fathi
Seyed J. Mowla
Ernst-Martin Füchtbauer
author_facet Karim Rahimi
Annette C. Füchtbauer
Fardin Fathi
Seyed J. Mowla
Ernst-Martin Füchtbauer
author_sort Karim Rahimi
collection DOAJ
description Background Cancer stem cells are believed to be a major reason for long-term therapy failure because they are multi-drug resistant and able to rest mitotically inactive in the hypoxic center of tumors. Due to their variable number and their often low proliferation rate, cancer stem cells are difficult to purify in decent quantities and to grow in cell culture systems, where they are easily outcompeted by faster growing more ‘differentiated’, i.e., less stem cell-like tumor cells. Methods Here we present a proof of principle study based on the idea to select cancer stem cells by means of the expression of a stem cell-specific gene. A selectable egfp-neo coding sequence was inserted in the last exon of the non-coding murine miR-302 host gene. As a stem cell specific regulatory element, 2.1 kb of the genomic region immediately upstream of the miR-302 host gene transcription start site was used. Stable transgenic CJ7 embryonic stem cells were used to induce teratomas. Results After three weeks, tumors were removed for analysis and primary cultures were established. Stem cell-like cells were selected from these culture based on G418 selection. When the selection was removed, stem cell morphology and miR-302 expression were rapidly lost, indicating that it was not the original ES cells that had been isolated. Conclusions We show the possibility to use drug resistance expressed from a regulatory sequence of a stem cell-specific marker, to isolate and propagate cancer stem cells that otherwise might be hidden in the majority of tumor cells.
first_indexed 2024-03-09T06:33:45Z
format Article
id doaj.art-2001e9cd44424152b8422aa42fa42423
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:33:45Z
publishDate 2019-03-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-2001e9cd44424152b8422aa42fa424232023-12-03T11:01:24ZengPeerJ Inc.PeerJ2167-83592019-03-017e663510.7717/peerj.6635Isolation of cancer stem cells by selection for miR-302 expressing cellsKarim Rahimi0Annette C. Füchtbauer1Fardin Fathi2Seyed J. Mowla3Ernst-Martin Füchtbauer4Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, DenmarkDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus C, DenmarkCellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, IranMolecular Genetics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, IranDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus C, DenmarkBackground Cancer stem cells are believed to be a major reason for long-term therapy failure because they are multi-drug resistant and able to rest mitotically inactive in the hypoxic center of tumors. Due to their variable number and their often low proliferation rate, cancer stem cells are difficult to purify in decent quantities and to grow in cell culture systems, where they are easily outcompeted by faster growing more ‘differentiated’, i.e., less stem cell-like tumor cells. Methods Here we present a proof of principle study based on the idea to select cancer stem cells by means of the expression of a stem cell-specific gene. A selectable egfp-neo coding sequence was inserted in the last exon of the non-coding murine miR-302 host gene. As a stem cell specific regulatory element, 2.1 kb of the genomic region immediately upstream of the miR-302 host gene transcription start site was used. Stable transgenic CJ7 embryonic stem cells were used to induce teratomas. Results After three weeks, tumors were removed for analysis and primary cultures were established. Stem cell-like cells were selected from these culture based on G418 selection. When the selection was removed, stem cell morphology and miR-302 expression were rapidly lost, indicating that it was not the original ES cells that had been isolated. Conclusions We show the possibility to use drug resistance expressed from a regulatory sequence of a stem cell-specific marker, to isolate and propagate cancer stem cells that otherwise might be hidden in the majority of tumor cells.https://peerj.com/articles/6635.pdfStem cell markerCancer stem cellsMiR-302/367Primary cell cultureG418 selectionTeratoma
spellingShingle Karim Rahimi
Annette C. Füchtbauer
Fardin Fathi
Seyed J. Mowla
Ernst-Martin Füchtbauer
Isolation of cancer stem cells by selection for miR-302 expressing cells
PeerJ
Stem cell marker
Cancer stem cells
MiR-302/367
Primary cell culture
G418 selection
Teratoma
title Isolation of cancer stem cells by selection for miR-302 expressing cells
title_full Isolation of cancer stem cells by selection for miR-302 expressing cells
title_fullStr Isolation of cancer stem cells by selection for miR-302 expressing cells
title_full_unstemmed Isolation of cancer stem cells by selection for miR-302 expressing cells
title_short Isolation of cancer stem cells by selection for miR-302 expressing cells
title_sort isolation of cancer stem cells by selection for mir 302 expressing cells
topic Stem cell marker
Cancer stem cells
MiR-302/367
Primary cell culture
G418 selection
Teratoma
url https://peerj.com/articles/6635.pdf
work_keys_str_mv AT karimrahimi isolationofcancerstemcellsbyselectionformir302expressingcells
AT annettecfuchtbauer isolationofcancerstemcellsbyselectionformir302expressingcells
AT fardinfathi isolationofcancerstemcellsbyselectionformir302expressingcells
AT seyedjmowla isolationofcancerstemcellsbyselectionformir302expressingcells
AT ernstmartinfuchtbauer isolationofcancerstemcellsbyselectionformir302expressingcells